These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 12477412)

  • 1. New technology platforms in the development of vaccines for the future.
    Glück R; Metcalfe IC
    Vaccine; 2002 Dec; 20 Suppl 5():B10-6. PubMed ID: 12477412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel approaches in the development of immunopotentiating reconstituted influenza virosomes as efficient antigen carrier systems.
    Glück R; Metcalfe IC
    Vaccine; 2003 Jan; 21(7-8):611-5. PubMed ID: 12531327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflexal V a trivalent virosome subunit influenza vaccine: production.
    Mischler R; Metcalfe IC
    Vaccine; 2002 Dec; 20 Suppl 5():B17-23. PubMed ID: 12477413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perspectives: towards a peptide-based vaccine against hepatitis C virus.
    Hunziker IP; Zurbriggen R; Glueck R; Engler OB; Reichen J; Dai WJ; Pichler WJ; Cerny A
    Mol Immunol; 2001 Dec; 38(6):475-84. PubMed ID: 11741697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biophysical validation of Epaxal Berna, a hepatitis A vaccine adjuvanted with immunopotentiating reconstituted influenza virosomes (IRIV).
    Glück R; Wälti E
    Dev Biol (Basel); 2000; 103():189-97. PubMed ID: 11214236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunopotentiating reconstituted influenza virosomes as a novel antigen delivery system.
    Cryz SJ; Glück R
    Dev Biol Stand; 1998; 92():219-23. PubMed ID: 9554278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccines for the prevention of respiratory viral infections: problems and current status.
    Olszewska W; Helson R; Openshaw PJ
    Expert Opin Investig Drugs; 2004 Jun; 13(6):681-9. PubMed ID: 15174954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA vaccines for biodefence.
    Garmory HS; Perkins SD; Phillpotts RJ; Titball RW
    Adv Drug Deliv Rev; 2005 Jun; 57(9):1343-61. PubMed ID: 15935877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccines in the prevention of viral pneumonia.
    Betts RF
    Semin Respir Infect; 1995 Dec; 10(4):282-7. PubMed ID: 8668856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunization against respiratory virus infections.
    Hobson D
    Mod Trends Immunol; 1967; 2():53-85. PubMed ID: 4298139
    [No Abstract]   [Full Text] [Related]  

  • 11. Vaccination against acute respiratory virus infections and measles in man.
    Osterhaus AD; de Vries P
    Immunobiology; 1992 Feb; 184(2-3):180-92. PubMed ID: 1587542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influenza virosome/DNA vaccine complex as a new formulation to induce intra-subtypic protection against influenza virus challenge.
    Kheiri MT; Jamali A; Shenagari M; Hashemi H; Sabahi F; Atyabi F; Saghiri R
    Antiviral Res; 2012 Sep; 95(3):229-36. PubMed ID: 22809863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The virosome concept for influenza vaccines.
    Huckriede A; Bungener L; Stegmann T; Daemen T; Medema J; Palache AM; Wilschut J
    Vaccine; 2005 Jul; 23 Suppl 1():S26-38. PubMed ID: 16026906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of recombinant Sendai virus vaccines for prevention of human parainfluenza and respiratory syncytial virus infections.
    Hurwitz JL
    Pediatr Infect Dis J; 2008 Oct; 27(10 Suppl):S126-8. PubMed ID: 18820573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peptide-loaded chimeric influenza virosomes for efficient in vivo induction of cytotoxic T cells.
    Amacker M; Engler O; Kammer AR; Vadrucci S; Oberholzer D; Cerny A; Zurbriggen R
    Int Immunol; 2005 Jun; 17(6):695-704. PubMed ID: 15843436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Global perspectives on maternal immunisation.
    Meulen AS; Bergquist S; Klugman KP
    Lancet Infect Dis; 2017 Jul; 17(7):685-686. PubMed ID: 28433706
    [No Abstract]   [Full Text] [Related]  

  • 17. Live-attenuated virus vaccines for respiratory syncytial and parainfluenza viruses: applications of reverse genetics.
    Murphy BR; Collins PL
    J Clin Invest; 2002 Jul; 110(1):21-7. PubMed ID: 12093883
    [No Abstract]   [Full Text] [Related]  

  • 18. Eleven years of Inflexal V-a virosomal adjuvanted influenza vaccine.
    Herzog C; Hartmann K; Künzi V; Kürsteiner O; Mischler R; Lazar H; Glück R
    Vaccine; 2009 Jul; 27(33):4381-7. PubMed ID: 19450630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunopotentiating reconstituted influenza virus virosome vaccine delivery system for immunization against hepatitis A.
    Glück R; Mischler R; Brantschen S; Just M; Althaus B; Cryz SJ
    J Clin Invest; 1992 Dec; 90(6):2491-5. PubMed ID: 1334977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro studies of core peptide-bearing immunopotentiating reconstituted influenza virosomes as a non-live prototype vaccine against hepatitis C virus.
    Hunziker IP; Grabscheid B; Zurbriggen R; Glück R; Pichler WJ; Cerny A
    Int Immunol; 2002 Jun; 14(6):615-26. PubMed ID: 12039913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.